Pregnancy outcomes in women with type 1 diabetes using insulin degludec

AIMS: To evaluate pregnancy outcomes in a real-world setting of pregnant women with type 1 diabetes using the ultra-long-acting insulin analog degludec compared to other long-acting insulin analogs throughout pregnancy. METHODS: This was a secondary analysis of a prospective cohort study. The prospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ringholm, Lene, Do, Nicoline Callesen, Damm, Peter, Mathiesen, Elisabeth Reinhardt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853215/
https://www.ncbi.nlm.nih.gov/pubmed/35147781
http://dx.doi.org/10.1007/s00592-021-01845-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853215/
https://www.ncbi.nlm.nih.gov/pubmed/35147781
http://dx.doi.org/10.1007/s00592-021-01845-0

Ejemplares similares